Ressources

Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.

 

 

We aimed to characterize perceptions of faculty, staff, and students about SUD stigma in professional healthcare training programs.

Original research | 2023
About prescribers, Stigma

We measured whether the associations of prescription opioid supply with drug overdose deaths vary by local socioeconomic conditions.

Original research | 2023
Overdose, Mortality, Equity

The COVID-19 pandemic reduced access to harm reduction (HR) structures in locations undergoing lockdown.

Original research | 2023
Digital health, Harm reduction
Guidelines | 2023
Clinical guidance, About prescribers, Substitution/OAT

Heroin-assisted treatment (HAT) is effective for individuals with severe opioid use disorder (OUD) who do not respond sufficiently to other opioid agonist treatments.

Original research | 2023
Safer supply, Evidence base, Barriers and enablers

This review summarizes literature on interventions for optimizing transitions in care from hospital to community for individuals with a substance use disorder (SUD).

Lit review | 2023
Transitions in care/treatment, Hospitals
Slide deck | 2023
Stigma

It is crucial to ensure that youth using unregulated opioids have access to evidence-based interventions, and yet, youth encounter critical gaps in the quality of such interventions.

Original research | 2023
Youth, Illegal drugs, Barriers and enablers

This study aimed to characterize how individuals accessing medical care obtain supplies and the impact of perceived barriers to accessing safer injection supplies.

Original research | 2023
Injecting drugs, Barriers and enablers, About PWUD, Harm reduction

We assessed changes in nonfatal opioid-related overdoses in Florida during the onset of the COVID-19 pandemic.

Original research | 2023
Overdose

Best-worst scaling (BWS) is a preference elicitation method from health economics that has never been applied to addiction care broadly, or iOAT specifically.

Original research | 2023
About PWUD, Substitution/OAT, Barriers and enablers

To assess the effectiveness and cost-effectiveness of office-based buprenorphine treatment (OBBT) in the U.S., in terms of fatal and nonfatal overdoses and deaths over five years, discounted lifeti

Original research | 2022
Substitution/OAT, Legal system/law enforcement, Overdose, Mortality

This study sought to determine how the COVID-19 pandemic impacted alcohol or drug use and its risk and protective factors among youth accessing integrated youth services.

Original research | 2022
Youth, Wrap-around services

Strategies are needed to increase reach and improve equitable delivery of drug checking services.

Original research | 2022
Drug checking, Barriers and enablers, Stigma

This study sought to assess the availability of OUD “best practices” in jails located in counties heavily impacted by opioid overdose in the U.S. and their related training and resource needs.

Original research | 2022
Legal system/law enforcement

The purpose of this study was to explore how shifts in provincial drug policy approaches, specifically the replacement of a Safe Consumption Site (SCS) with a smaller mobile Overdose Prevention Sit

Original research | 2023
Harm reduction, Policy/Regulatory, About PWUD, SCS/OPS, Barriers and enablers
Page Web | 2022
s'injecter les drogues, la réduction des méfaits
Webpage | 2022
Injecting drugs, Harm reduction

The Internet offers increased availability and accessibility of medicinal pharmaceuticals including those containing opioids, sedatives and gamma-aminobutyric acid (GABA) drugs through both legal a

Original research | 2022
Illegal drugs, Digital health

Deaths involving opioids typically result from lethal respiratory depression, and it is currently unknown how co-use of psychostimulants with opioids affects respiratory toxicity.

Original research | 2022
Stimulants, Overdose

Affiner votre recherche

Mots clés
Format
Région